
Invento Robotics provides in-home companion robots that help seniors with dementia stay safer, manage medication, and maintain social connections. The company combines AI-driven robotics, telepresence avatars (Mitra robot), and remote nurse monitoring to deliver fall detection, physiotherapy guidance, medication reminders, personalized content, and social engagement. Its product is a robotics + cloud platform (B2B SaaS + hardware) that integrates with remote caregiving workflows and allows third-party age-tech services to plug into the system. The solution targets care providers and families seeking to enable aging in place while reducing the cost of cognitive care. Invento positions its offering for deployment at scale across home care and senior living markets.

Invento Robotics provides in-home companion robots that help seniors with dementia stay safer, manage medication, and maintain social connections. The company combines AI-driven robotics, telepresence avatars (Mitra robot), and remote nurse monitoring to deliver fall detection, physiotherapy guidance, medication reminders, personalized content, and social engagement. Its product is a robotics + cloud platform (B2B SaaS + hardware) that integrates with remote caregiving workflows and allows third-party age-tech services to plug into the system. The solution targets care providers and families seeking to enable aging in place while reducing the cost of cognitive care. Invento positions its offering for deployment at scale across home care and senior living markets.
Company: Invento Robotics
Founded: 2016
HQ: Plano, Texas (team presence reported in Bengaluru, India)
Flagship product: Mitra — a humanoid service/telepresence robot
Focus: In-home companion robots for senior care and humanoid/service robots for customer engagement
Total funding (reported): 689127 USD
Senior-care (dementia safety, medication management, social connection) and customer-engagement/service robots for banks, malls and events.
2016
Robotics
Crunchbase lists Windrose Capital as lead investor in a Seed round announced Jan 20, 2020.
Dealroom and Crunchbase list a MassChallenge support-program / non-equity assistance entry (Jun 2021).
Investor activity lists ITI Growth Opportunities Fund investing on May 14, 2025.
“Backed by a mix of accelerators/support programs and investors, including MassChallenge, Windrose Capital, Chiripal Group and ITI Growth Opportunities Fund; Crunchbase reports a total of nine investors.”